The 10% increase in reimbursement for the index hospital stay and the observed mean 8% decrease in mortality at discharge after network implementation translated into short term mean costs per saved life of €7727 (reference: 2005 German reimbursement level).
When only cost of SBI itself would be included in the denominator of the ICER, mean costs per QALY and per life year gained would be respectively €1,100 and €700,- for the SBI scenario compared to current practice scenario.
Table 3 shows mean costs per participant.
The secondary outcome was the costs of added recruitment years, reported as total costs and mean costs per birth episode.
They include discharges, total costs, and mean costs per discharge for selected PPCs during the period before implementation of the demonstration program.
For each resource category, mean costs per quarter and per capita were calculated based on quarterly data collected from 1 year.
Table 3 presents the amount of care consumption and mean costs per patient during two and three years of follow-up.
In order to improve comparability with other studies, mean costs per week were extrapolated to 1 year by multiplication with a factor of 52.
Health care costs related to ADEs in this base case totalled 816 million Euros, mean costs per case were 381 Euros.
Observed mean costs per person/year were €3,348.66 (median €1,314.99) in patients with diabetes and €831.22 (median €110.00) in patients without diabetes.
The health outcomes of these patients are presented in Table 2 and the amount of care consumption and mean costs per patient during two and three years of follow-up are presented in Table 3.
